Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,656,895
+$2,982,019 QoQ
Shares Held
1,047,985
+21.0% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 172 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Derivatives in CRVS
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$600,000
PutShares
150,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. CRVS ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in CRVS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,656,895 | 1,047,985 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,674,876 | 866,362 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,303,529 | 688,770 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $600,000 | 150,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $5,206,098 | 1,637,138 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $159,000 | 50,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $385,416 | 121,200 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $969,420 | 181,200 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $828,720 | 154,901 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $806,784 | 152,800 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $1,643,600 | 311,288 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $372,368 | 204,598 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,440 | 23,281 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $71,869 | 40,835 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $157,715 | 108,024 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,846,774 | 2,029,423 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,614,588 | 1,899,516 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,855,290 | 2,265,312 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,661,063 | 2,687,943 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,466,603 | 2,723,539 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,037,342 | 2,920,059 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,847,236 | 588,272 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $499,004 | 103,100 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $350,931 | 131,435 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $305,215 | 99,096 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $432,960 | 121,618 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,528,383 | 381,143 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,244,258 | 1,192,742 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,177,011 | 1,031,759 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||